Stonegate Capital Updates GoHealth (GOCO) Coverage After 4Q25 Results

GoHealth Inc. (NASDAQ: GOCO) is back in focus after Stonegate Capital Partners updated its coverage on the company following fourth-quarter and full-year 2025 results. The new coverage note says GoHealth is choosing durability over raw volume in a difficult Medicare Advantage market, where insurers are putting more weight on retention, member quality, renewal stability, and disciplined unit economics instead of broad enrollment growth. Stonegate said fiscal 2025 net revenue came in at $361.8 million, while management stayed focused on protecting liquidity, preserving strategic flexibility, and defending the long-term value of its large commissions receivable base.

Why Stonegate’s update matters

Stonegate’s updated view matters because it frames GoHealth’s recent performance not simply as a revenue slowdown, but as part of a larger strategic repositioning. In the firm’s view, the latest quarter did not dramatically change the near-term investment story. Instead, it reinforced management’s message that the company is trying to protect the quality of its existing business, preserve cash, and remain flexible until industry conditions improve. Stonegate highlighted three major themes: durability over volume, optionality as a differentiator, and portfolio repositioning through selective investment in Special Needs Plans, automation, artificial intelligence, and related offerings such as GoHealth Protect.

This is important because the Medicare Advantage distribution market has changed sharply over the past year. Health plans have become more cautious, especially after pressure on margins and renewal economics. That shift has forced brokers, marketplaces, and distribution partners like GoHealth to move more carefully. Rather than chase every possible enrollment, the company is trying to improve consumer fit, protect its back book, and focus on business that can deliver better long-term value. That broader context helps explain why a weaker revenue profile does not automatically mean management sees its strategy as failing.

What Stonegate said about GoHealth’s 4Q25 performance

According to the April 16, 2026 release, Stonegate said GoHealth’s fourth-quarter 2025 results continued to reflect a Medicare Advantage environment shaped by tighter carrier discipline. The research note said management prioritized retention, member quality, and liquidity over volume during the Annual Enrollment Period. Stonegate also pointed to the importance of GoHealth’s roughly $925 million commissions receivable asset, saying the company’s retention focus supports the long-term value and durability of that asset.

Stonegate’s message was clear: the company is operating in a market that rewards careful underwriting, stable renewals, and disciplined economics. In that kind of market, a company that slows down sales activity on purpose may still be trying to create stronger long-term value. The firm said GoHealth is keeping room for future opportunity by staying financially disciplined now, even while current volumes remain pressured. Stonegate also said continued investment in SNPs, AI, automation, and GoHealth Protect could support a more durable and efficient growth profile over time.

GoHealth’s own explanation of the year

GoHealth’s March 31, 2026 full-year results release lines up closely with Stonegate’s interpretation. Chief Executive Officer Vijay Kotte said the Medicare Advantage market remains in a “structural reset” going into 2026, with health plans continuing to prioritize retention, member quality, and disciplined unit economics. He said GoHealth’s pullback in 2025 was intentional and designed to match market realities, while still helping consumers enroll in plans that truly fit their needs. Management also stressed that the company is maintaining focus on cash, improving its capital structure, and continuing tactical investment in technology and AI.

The company said it aligned its operating model around several priorities: improving retention, intentionally reducing Medicare Advantage activity where first-renewal probability did not support attractive economics, staying strong in Special Needs Plans, investing in proprietary AI and automation, preserving strategic flexibility, and remaining ready for possible industry consolidation. In simple terms, GoHealth is saying it would rather write fewer but better enrollments today than chase growth that may not hold up tomorrow.

Revenue picture: a sharp decline, but not a surprise

On the headline numbers, 2025 was a much weaker year than 2024. GoHealth reported $361.845 million in net revenue for 2025, down from $798.894 million the year before, a decline of about 54.7%. Stonegate’s update noted that the 2025 total implies a materially lower fourth-quarter revenue base year over year as the planned Medicare Advantage pullback continued through AEP. That large drop shows just how dramatically the company reduced volume in response to weaker market economics.

Even so, the company and Stonegate are both signaling that the revenue decline should be viewed through the lens of strategy rather than only weakness. The operating model changed because the economics of writing new business changed. When carriers become more selective and emphasize profitability, brokers face a choice: keep pushing volume and risk lower-quality business, or slow down and protect future value. GoHealth chose the second path. That decision hurts reported revenue in the near term, but management believes it can support stronger retention and longer-lived value over time.

Profitability and losses paint a tougher picture

The revenue decline was not the only challenge. GoHealth reported a net loss attributable to GoHealth, Inc. of $257.126 million for 2025, while total net loss reached $497.755 million. Adjusted EBITDA moved to a loss of $35.109 million, compared with positive Adjusted EBITDA of $120.319 million in 2024. Adjusted EBITDA margin fell to -9.7% from 15.1% a year earlier. The company also recorded nearly $260 million in indefinite and long-lived asset impairment charges, which weighed heavily on results.

These numbers show that the transition is costly. GoHealth did reduce several expense lines, including marketing and advertising, consumer care and enrollment, technology spending, and amortization of intangible assets. But those cuts were not enough to offset the revenue decline and the impairment charge. That means investors looking at the stock today are seeing a company in a reset period, not one that has already completed its turnaround. Stonegate acknowledged as much by saying the quarter reinforced the near-term thesis rather than changing it.

Cash and liquidity remain central to the story

Both Stonegate and GoHealth placed major emphasis on liquidity. At December 31, 2025, GoHealth reported $32.904 million in cash and cash equivalents. Net cash used in operating activities for the year was $121.947 million, compared with $21.607 million used in 2024. Those figures explain why management keeps talking about cash discipline and capital allocation. In a market reset, protecting liquidity can matter just as much as protecting revenue.

GoHealth’s CFO, Brendan Shanahan, said operating cash flow will remain the primary lens for capital allocation decisions. That comment gives investors a useful clue about what to watch next. Instead of focusing only on topline growth, the market may pay closer attention to how efficiently the company preserves cash, how its renewal book performs, and whether management can improve capital structure over time.

The $925 million commissions receivable asset is a major piece of the case

One of the most important points in both the Stonegate update and the company’s own messaging is the value of the commissions receivable asset. At year-end 2025, GoHealth reported $239.644 million in current commissions receivable and $685.527 million in non-current commissions receivable, totaling roughly $925 million. That is a very large asset relative to the company’s current revenue base, and it is directly tied to the long-term value of previously written business.

Why does this matter so much? Because commissions receivable depends on how durable and valuable the underlying member book remains over time. If members stay enrolled, renew, and remain economically attractive, that asset has more staying power. If retention weakens, the value becomes less certain. That is why Stonegate said GoHealth’s emphasis on retention also supports the long-term durability of the receivable, and why management keeps linking consumer fit, renewal economics, and back-book quality together.

Special Needs Plans remain a bright spot

GoHealth continues to describe Special Needs Plans, or SNPs, as an area of relative strength. In its 2025 results release, the company said it maintained leadership in key SNP categories thanks to its proprietary enrollment and servicing tools, technology, and experience. It also said health plans continued to pursue targeted growth in these populations because member stability, renewal duration, and outcomes remained especially important. Stonegate also highlighted continued investment in SNPs as part of the company’s portfolio repositioning.

This matters because not all Medicare-related business is behaving the same way. In a pressured market, niches with stronger retention or better economics can become more valuable. If GoHealth can defend or expand its position in SNPs while keeping acquisition costs under control, that could give it a more stable platform for future growth. For now, though, SNP strength appears to be more of a strategic support pillar than a complete solution to broader market weakness.

AI and automation are part of the long game

Another major part of the story is technology. GoHealth said it is continuing targeted investment in proprietary agentic AI and automation to lower customer acquisition costs, improve year-one payback, reduce operational friction, and free agents to focus on higher-value advisory work. Stonegate echoed that point by saying investments in automation and AI should support a more durable and efficient growth profile over time.

In practical terms, management appears to be using this lower-volume period to improve the machine behind the business. If the market stabilizes later, a leaner and more automated GoHealth could be able to ramp faster without carrying the same cost structure it had in earlier growth phases. Of course, that remains a forward-looking view, not a guaranteed outcome. Still, the consistency between the company’s message and Stonegate’s update suggests that technology investment is not being treated as a side project. It is central to how GoHealth hopes to restore efficiency.

GoHealth Protect and broader portfolio repositioning

Stonegate specifically mentioned GoHealth Protect as part of the company’s repositioning effort. The company’s own metric definitions show that GoHealth Protect contributes to sales per submission and is part of how GoHealth measures operating productivity. While the latest releases did not provide an extended breakout for this segment, its inclusion in both performance metrics and Stonegate’s commentary suggests management sees it as one of several products that can broaden the business beyond the most pressured areas of Medicare Advantage distribution.

That broader repositioning matters because diversified revenue streams can reduce dependence on one unstable part of the market. Right now, GoHealth is clearly still tied very closely to Medicare Advantage trends. But the company’s strategic language suggests it wants to emerge from this cycle with a more flexible, more efficient, and potentially more diversified operating model.

The bigger industry backdrop: a Medicare Advantage reset

The phrase “structural reset” shows up repeatedly in GoHealth’s messaging, and it helps explain nearly everything happening in the business. According to management, health plans remain focused on margin integrity, renewal stability, and long-term member value. That means distribution partners are being judged less on how many members they can bring in and more on whether those members stay, fit the plans well, and support sustainable economics. Stonegate’s note used nearly the same language, saying carriers remain focused on margin stability, renewal durability, and disciplined unit economics instead of broad enrollment growth.

This backdrop has major consequences. It can reduce marketing intensity, shrink volumes during enrollment seasons, increase focus on consumer quality, and make retention more valuable than aggressive acquisition. It can also favor companies that have data, servicing tools, and operational discipline over those that rely mainly on brute-force lead generation. GoHealth is presenting itself as one of the companies built to survive that transition. Whether the market fully agrees will likely depend on future cash flow, retention trends, and balance-sheet stability.

Could industry consolidation create opportunity?

One of the more interesting parts of GoHealth’s strategy is its repeated claim that the broker landscape is fragmented and likely to consolidate. The company says it wants to stay ready for disciplined integration opportunities with the right partners at the right time. Stonegate likewise said optionality is a key differentiator and that cost discipline plus the board’s strategic review framework may help the company preserve flexibility and capitalize on industry dislocation.

That does not mean a deal is around the corner. But it does suggest that management sees the current downturn as a period that could eventually create openings. Companies that protect cash, maintain core technology, and hold onto strong servicing capabilities may be better positioned if weaker competitors struggle. In that scenario, GoHealth’s current defensive posture could become an offensive advantage later. Still, any such outcome depends on market conditions, access to capital, and management execution.

How investors may read Stonegate’s update

For investors, Stonegate’s update does not read like a call that near-term pain is over. Instead, it sounds more like a vote of confidence in management’s discipline during a difficult cycle. The firm did not hide the pressure on volumes or the weak revenue base. But it emphasized that the company’s strategy is built around preserving the value of existing business, protecting liquidity, and investing selectively in areas that may matter more when the market normalizes.

That framing may appeal more to long-term investors than to those looking for quick growth. The bullish case would likely focus on retention, cash discipline, the large commissions receivable asset, technology leverage, leadership in SNPs, and possible consolidation upside. The cautious case would focus on steep revenue contraction, continuing operating cash burn, large losses, and uncertainty around how long the Medicare Advantage reset will last. Both views can be supported by the current data, which is why future execution will matter so much.

What to watch next for GoHealth

Looking ahead, several indicators stand out. First, investors will likely watch whether retention and renewal performance continue to support the value of commissions receivable. Second, cash usage and liquidity will remain central. Third, the company’s efforts in SNPs, AI, automation, and GoHealth Protect will be closely monitored to see whether they can improve operating efficiency and diversify value creation. Fourth, any evidence that Medicare Advantage carrier discipline is easing could change the company’s growth outlook quickly.

Another key issue is whether GoHealth can move from a defensive stance to a more balanced one without giving up quality. Management has argued that it wants to be ready to ramp when conditions improve. That means the company must keep enough infrastructure, data capability, and agent support in place to grow again, while still guarding cash in the present. That balancing act is never easy, especially after such a sharp revenue drop.

Bottom line

Stonegate Capital’s latest coverage update presents GoHealth as a company that is deliberately sacrificing near-term volume to protect longer-term value in a tougher Medicare Advantage market. The headline numbers are rough: revenue fell sharply, losses widened, and cash usage increased. But both Stonegate and GoHealth argue that the company is not simply shrinking. Instead, it is trying to rebuild around higher-quality retention, stronger consumer fit, disciplined economics, cash preservation, targeted AI investment, SNP leadership, and strategic flexibility.

Whether that strategy pays off will depend on factors both inside and outside the company’s control. Internally, GoHealth must keep improving efficiency and protecting the durability of its back book. Externally, the Medicare Advantage market must eventually become more supportive of healthy enrollment economics. For now, Stonegate’s message is that the quarter did not rewrite the story. It confirmed it. And that story is about patience, discipline, and positioning for a better environment ahead. Sources: Newsfile release on April 16, 2026 and GoHealth investor relations release on March 31, 2026.

Additional company context

GoHealth describes itself as a leading health insurance marketplace and Medicare-focused digital health company. The company says its technology platform uses machine-learning models built on more than two decades of insurance purchasing behavior to help match consumers with plans that fit their needs. It also says it has helped enroll millions of consumers into Medicare plans since its inception. That broader description helps explain why management is leaning so heavily on technology, servicing quality, and consumer fit during this industry reset. More company information is available at https://www.gohealth.com.

Editor’s note: This rewritten article is based on the public releases from Stonegate Capital Partners and GoHealth and is intended as a detailed news-style summary in English, not as investment advice.

#SlimScan #GrowthStocks #CANSLIM